Spyre Therapeutics Gross Loans (Quarterly) Analysis

Spyre Therapeutics, Inc. (SYRE)

43.15 -0.73 (-1.66%) USD | NASDAQ | Feb 26, 16:00

41.70 -1.45 (-3.36%) After-Hours: 05:40

View Gross Loans (Quarterly) for SYRE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Gross Loans (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Gross Loans (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Gross Loans (Quarterly) Benchmarks

Start Trial

PTC Therapeutics, Inc.	--
Tandem Diabetes Care, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--